Toll-Like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury Through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling
Molecular Medicine - United States
doi 10.2119/molmed.2014.00076
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Springer Science and Business Media LLC